03.08. Department of Food Engineering

Bibliometrics Email Alert

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Refined By:
Author:  Sezgin, Efe
Type:  Article
Author:  Soran, Atilla

Results 1-12 of 12 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
12022Adding pneumatic compression therapy in lower extremity lymphedema increases compliance of treatment, while decreasing the infection rate
2Oct-2022ASO visual abstract: Intervention for hepatic and pulmonary METastases in breast cancer patients-prospective, multi-institutional registry study: IMET; Protocol MF 14-02
32020The correlation of Magee Equations (TM) and Oncotype DX (R) recurrence score from core needle biopsy tissues in predicting response to neoadjuvant chemotherapy in ER+ and HER2- breast cancer
42023Early detection of breast cancer-related lymphedema: Accuracy of indocyanine green lymphography compared with bioimpedance spectroscopy and subclinical lymphedema symptoms
52021The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (Protocol BOMET MF 14-01): A multi-center, prospective registry study
6Jun-2018Factors related to recurrence of idiopathic granulomatous mastitis: what do we learn from a multicentre study?
72016The impact of Onco type DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer
8Oct-2022Intervention for hepatic and pulmonary metastases in breast cancer patients: Prospective, multi-institutional registry Study-IMET, Protocol MF 14-02
92021Lymphedema after sentinel lymph node biopsy: Who is at risk?
102021A novel first-line treatment alternative for noncomplicated idiopathic granulomatous mastitis: Combined intralesional steroid injection with topical steroid administration
112018Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: Protocol MF07-01
12Jul-2021The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q